Androgens and Prostate Cancer Bone Metastases: Effects on Both the Seed and the Soil

被引:2
|
作者
Yang, Wei [1 ]
Levine, Alice C. [1 ]
机构
[1] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, Dept Med, New York, NY 10029 USA
关键词
Androgens; Androgen receptor; Prostate cancer; Bone metastases; ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; OSTEOBLASTIC LINEAGE; TUMOR PROGRESSION; STROMAL CELLS; SEX STEROIDS; KAPPA-B; RECEPTOR; EXPRESSION;
D O I
10.1016/j.ecl.2011.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Androgens are essential for normal prostate development and are necessary, but not sufficient, for the development of prostate cancer (PCa). Androgen deprivation therapy has long been the mainstay of treatment for PCa bone metastases, providing palliation of symptoms in the majority of patients, followed by relapse and progression. The majority of published preclinical studies demonstrate a stimulatory effect of androgens and androgen receptor signaling on the multistep process of PCa bone metastases, including androgenic promotion of local PCa growth, angiogenesis, invasion, bone targeting, stimulation of PCa growth factors that enhance osteoclastogenesis, and enhancement of Wnt signaling in osteoblasts.
引用
收藏
页码:643 / +
页数:12
相关论文
共 50 条
  • [31] Prostate cancer metastases to shoulder arthroplasty - Bone scintigraphy
    Nguyen, Ba D.
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (11) : 858 - 859
  • [32] Biphosphonates in the treatment of bone metastases in prostate cancer.
    Paule, B
    Cicco, A
    PROGRES EN UROLOGIE, 2001, 11 (06): : 1205 - 1212
  • [33] Metabolic and Osteogenic pattern of Prostate Cancer Bone Metastases
    Garcia, J. R.
    Riera, E.
    Valls, E.
    Soler, M.
    Moragas, M.
    Lomena, F.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (01): : 33 - 36
  • [34] Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
    Nieder, Carsten
    Haukland, Ellinor
    Pawinski, Adam
    Dalhaug, Astrid
    BMC CANCER, 2010, 10
  • [35] Targeted α-Particle Therapy of Bone Metastases in Prostate Cancer
    Jadvar, Hossein
    Quinn, David I.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (12) : 966 - 971
  • [36] Risk factors for the development of bone metastases in prostate cancer
    Petrylak, Daniel P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (11) : 677 - 682
  • [37] Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
    Carsten Nieder
    Ellinor Haukland
    Adam Pawinski
    Astrid Dalhaug
    BMC Cancer, 10
  • [38] ETA antagonists in prostate cancer and the relationship to bone metastases
    Nelson, JB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P2 - P2
  • [39] Survival markers related to bone metastases in prostate cancer
    Salminen, E. K.
    Kallioinen, M. J.
    Ala-Houhala, M. A.
    Vihinen, P. P.
    Tiitinen, S. L.
    Varpula, M.
    Vahlberg, T. J.
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4879 - 4884
  • [40] Treatment strategy for prostate cancer patients with bone metastases
    Suzuki, Hiroyoshi
    Kato, Seiji
    Wakai, Ken
    Fang-ching, Lee
    Oka, Ryo
    Nishimi, Daisuke
    Endo, Takumi
    Yano, Masashi
    Kamijima, Shuichi
    Kamiya, Naoto
    ANNALS OF ONCOLOGY, 2017, 28 : 33 - 33